CLASS II Drug recall · Reported 13 Mar 2019 · FDA Enforcement Report

Topical Solution USP Hydrogen Peroxide First Aid Antiseptic recalled

Vi-Jon is recalling Topical Solution USP Hydrogen Peroxide First Aid Antiseptic Oral Debriding Agent, distributed in Ohio. The recall was initiated on 20 Feb 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 0384244 Exp. 01/2020
Quantity recalled6756 32 oz bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0520-2019
FDA event ID
82215
Recalling firm
Vi-Jon, Smyrna, TN
Classification
Class II
Status
Terminated
Recall initiated
20 Feb 2019
FDA classified
7 Mar 2019
Reported
13 Mar 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

20 Feb 2019Recall initiated by company
7 Mar 2019Classified by FDA+15 days
13 Mar 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Cross Contamination: Presence of IPA in finished product.

Product as listed by the FDA

Topical Solution USP Hydrogen Peroxide First Aid Antiseptic Oral Debriding Agent 32 Fl. Oz. (1 QT) 946 mL bottle, Distributed By: Discount Drug Mart 211 Commerce Drive, Medina, Ohio 44256 NDC 53943-871-45 UPC 0-93351-12758-8

Where it was distributed

Distributed in Ohio

Ohio

Questions about this recall

Why was it recalled?

Cross Contamination: Presence of IPA in finished product.

Which lots are affected?

Lot: 0384244 Exp. 01/2020

Where was it sold?

Distributed in Ohio

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Vi-Jon

All 29